Cargando...
Survival outcomes based on systemic agent used concurrently with radiation in human-papillomavirus associated oropharyngeal cancer
PURPOSE: To investigate survival outcomes of patients treated with concurrent cetuximab and radiotherapy for primary management of both HPV positive and negative OPSCC, and compare the results to traditional platinum-based therapy. We hypothesize that the use of cetuximab in the HPV positive OPSCC p...
Gardado en:
| Publicado en: | Oncotarget |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5642607/ https://ncbi.nlm.nih.gov/pubmed/29050332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20197 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|